Latest filing published 17 Mar 2026 for Tevogen Bio Holdings Inc., €127.
Filing timeline
BuySaleInsider track record
Neal Flomenberg: trading record in brief
Neal Flomenberg discloses dealings in Tevogen Inc. to SEC (Form 4). We count 13 filings; the first trade dates from 14 February 2024 and the latest from 13 March 2026.
On the market, this insider has only sold: 11 sales, €2.3M in total. The rest of the record consists of 2 share grants. In 2026 alone, the filings show no purchases and 3 sales.
Most recently, on 17 March 2026, the filings show an open-market sale worth €2,826 in Tevogen Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Neal Flomenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19 shares@ US$7.750.0% of flowCommon StockSEC:0001123292-26-000465:0
- 300,000 shares0Common StockSEC:0001062993-25-012329:0
- 232,968 shares@ US$1.0912.0% of flowCommon StockSEC:0001062993-25-005533:0
- 71,273 shares@ US$1.143.9% of flowCommon StockSEC:0001062993-25-005198:0
- 14,639 shares@ US$1.280.9% of flowCommon StockSEC:0001062993-25-004850:0
- 1,078,600 shares@ US$1.6283.2% of flowCommon StockSEC:0001062993-24-017785:0
- 5,332,902 sharesCommon StockSEC:0001062993-24-003490:0
7 of 7 declarations